{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Amyotrophic lateral sclerosis or motor neuron disease",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_riluzole",
          "name": "Riluzole"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_edaravone",
          "name": "Edaravone"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_cilobradine",
          "name": "Cilobradine"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_tiglutik",
          "name": "Tiglutik"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_nuedexta",
          "name": "Nuedexta"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_masitinib",
          "name": "Masitinib"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_glecaprevir_pibrentasvir",
          "name": "Glecaprevir/Pibrentasvir"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_anavex_2_73",
          "name": "Anavex 2-73"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_tirasemtiv",
          "name": "Tirasemtiv"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_tofersen",
          "name": "Tofersen"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_sodium_phenylbutyrate",
          "name": "Sodium phenylbutyrate"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_fuspiron",
          "name": "Fuspiron"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_riluzole",
          "type": "Target",
          "label": "Riluzole Off-target Mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_edav",
          "type": "Target",
          "label": "Edaravone Off-target Mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cilobradine",
          "type": "Target",
          "label": "Cilobradine Off-target Mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_tiglutik",
          "type": "Target",
          "label": "Tiglutik Off-target Mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_nuedexta",
          "type": "Target",
          "label": "Nuedexta Off-target Mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_masitinib",
          "type": "Target",
          "label": "Masitinib Off-target Mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_glecaprevir_pibrentasvir",
          "type": "Target",
          "label": "Glecaprevir/Pibrentasvir Off-target Mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_anavex_2_73",
          "type": "Target",
          "label": "Anavex 2-73 Off-target Mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_tirasemtiv",
          "type": "Target",
          "label": "Tirasemtiv Off-target Mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_tofersen",
          "type": "Target",
          "label": "Tofersen Off-target Mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_sodium_phenylbutyrate",
          "type": "Target",
          "label": "Sodium Phenylbutyrate Off-target Mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_fuspiron",
          "type": "Target",
          "label": "Fuspiron Off-target Mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_riluzole",
          "target": "n_ot_riluzole",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "存在潜在的离靶作用"
        },
        {
          "source": "drug_edav",
          "target": "n_ot_edav",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点途径"
        },
        {
          "source": "drug_cilobradine",
          "target": "n_ot_cilobradine",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "具潜在离靶或反向作用"
        },
        {
          "source": "drug_tiglutik",
          "target": "n_ot_tiglutik",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能干扰其他机制"
        },
        {
          "source": "drug_nuedexta",
          "target": "n_ot_nuedexta",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "有可能抑制非靶点功能"
        },
        {
          "source": "drug_masitinib",
          "target": "n_ot_masitinib",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能对非靶器官有作用"
        },
        {
          "source": "drug_glecaprevir_pibrentasvir",
          "target": "n_ot_glecaprevir_pibrentasvir",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "对其他靶以外路径的干扰风险"
        },
        {
          "source": "drug_anavex_2_73",
          "target": "n_ot_anavex_2_73",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "影响非目标机制的风险"
        },
        {
          "source": "drug_tirasemtiv",
          "target": "n_ot_tirasemtiv",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能诱发非靶向反应"
        },
        {
          "source": "drug_tofersen",
          "target": "n_ot_tofersen",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能影响其他机制"
        },
        {
          "source": "drug_sodium_phenylbutyrate",
          "target": "n_ot_sodium_phenylbutyrate",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "有潜在的副作用机制"
        },
        {
          "source": "drug_fuspiron",
          "target": "n_ot_fuspiron",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点通路"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": []
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "可能存在对其他靶器官的不利影响",
        "confidence": "medium"
      },
      {
        "id": "K2",
        "text": "疗效欠缺明确机制保障",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "各药物作用机制是否充分及安全",
      "对靶标相关神经保护效果的验证"
    ],
    "falsification_tests": [
      "是否有证据表明这些药物对ALS的长期疗效？",
      "药物潜在副作用与靶点功能是否存在冲突？"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 提供支持药物疗效的具体机制证据",
      "评估潜在的靶外作用影响"
    ]
  }
}